AQUESTIVE THERAPEUTICS INC shareholders Q3 2023

AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 49 filers reported holding AQUESTIVE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 2.0%.

AQUESTIVE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Bratton Capital Management, L.P. 9,810,958$1,501,766100.00%
Vahanian & Associates Financial Planning Inc. 722,108$1,104,8253.55%
Latash Investments, LLC 243,134$371,9950.32%
ARMISTICE CAPITAL, LLC 4,800,000$7,344,0000.11%
Bracebridge Capital, LLC 428,571$655,7140.10%
XTX Topco Ltd 52,980$81,0590.01%
GSA CAPITAL PARTNERS LLP 100,854$1540.01%
OCCUDO QUANTITATIVE STRATEGIES LP 59,829$91,5380.01%
D.B. Root & Company, LLC 12,950$19,8140.01%
Heron Bay Capital Management 14,025$21,4580.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 147,856$226,2200.01%
ACADIAN ASSET MANAGEMENT LLC 550,484$8410.00%
HBK Sorce Advisory LLC 42,348$64,7930.00%
Renaissance Technologies 1,129,189$1,7280.00%
Corient Private Wealth LLC 457,326$699,7090.00%
Connor, Clark & Lunn Investment Management Ltd. 247,828$379,1770.00%
Financial Advocates Investment Management 20,000$30,6000.00%
Tower Research Capital LLC (TRC) 10,873$16,6350.00%
Beacon Pointe Advisors, LLC 60,000$91,8000.00%
MARSHALL WACE, LLP 310,809$475,5380.00%
External links

This page lists AQUESTIVE THERAPEUTICS INC's shareholders in Q3 2023. To view AQUESTIVE THERAPEUTICS INC's shareholder history, click here.